Literature DB >> 31875243

166Ho microsphere scout dose for more accurate radioembolization treatment planning.

C Chiesa1, M Maccauro2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31875243     DOI： 10.1007/s00259-019-04617-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  24 in total

1.  Resin Versus Glass Microspheres for 90Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry.

Authors:  Axel Van Der Gucht; Mario Jreige; Alban Denys; Paul Blanc-Durand; Ariane Boubaker; Anastasia Pomoni; Periklis Mitsakis; Marina Silva-Monteiro; Silvano Gnesin; Marie Nicod Lalonde; Rafael Duran; John O Prior; Niklaus Schaefer
Journal:  J Nucl Med       Date:  2017-01-12       Impact factor: 10.057

2.  Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging.

Authors:  A P Hunt; M Frier; R A Johnson; S Berezenko; A C Perkins
Journal:  Eur J Pharm Biopharm       Date:  2005-09-08       Impact factor: 5.571

3.  Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.

Authors:  Karin Knesaurek; Josef Machac; M Muzinic; Michael DaCosta; Zhuangyu Zhang; Sherif Heiba
Journal:  Technol Cancer Res Treat       Date:  2010-06

4.  Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

Authors:  C Chiesa; M Mira; M Maccauro; C Spreafico; R Romito; C Morosi; T Camerini; M Carrara; S Pellizzari; A Negri; G Aliberti; C Sposito; S Bhoori; A Facciorusso; E Civelli; R Lanocita; B Padovano; M Migliorisi; M C De Nile; E Seregni; A Marchianò; F Crippa; V Mazzaferro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-27       Impact factor: 9.236

5.  Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.

Authors:  Paul Haste; Mark Tann; Scott Persohn; Thomas LaRoche; Vasantha Aaron; Thibault Mauxion; Nikhil Chauhan; Matthew R Dreher; Matthew S Johnson
Journal:  J Vasc Interv Radiol       Date:  2017-02-24       Impact factor: 3.464

6.  Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.

Authors:  Maarten L J Smits; Johannes F W Nijsen; Maurice A A J van den Bosch; Marnix G E H Lam; Maarten A D Vente; Willem P T M Mali; Alfred D van Het Schip; Bernard A Zonnenberg
Journal:  Lancet Oncol       Date:  2012-08-22       Impact factor: 41.316

7.  Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Authors:  Valérie Vilgrain; Helena Pereira; Eric Assenat; Boris Guiu; Alina Diana Ilonca; Georges-Philippe Pageaux; Annie Sibert; Mohamed Bouattour; Rachida Lebtahi; Wassim Allaham; Hélène Barraud; Valérie Laurent; Elodie Mathias; Jean-Pierre Bronowicki; Jean-Pierre Tasu; Rémy Perdrisot; Christine Silvain; René Gerolami; Olivier Mundler; Jean-Francois Seitz; Vincent Vidal; Christophe Aubé; Frédéric Oberti; Olivier Couturier; Isabelle Brenot-Rossi; Jean-Luc Raoul; Anthony Sarran; Charlotte Costentin; Emmanuel Itti; Alain Luciani; René Adam; Maïté Lewin; Didier Samuel; Maxime Ronot; Aurelia Dinut; Laurent Castera; Gilles Chatellier
Journal:  Lancet Oncol       Date:  2017-10-26       Impact factor: 41.316

8.  Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization.

Authors:  Mattijs Elschot; Johannes Franciscus Wilhelmus Nijsen; Alida Johanna Dam; Hugo Wilhelmus Antonius Maria de Jong
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

Review 9.  Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.

Authors:  Marta Cremonesi; Carlo Chiesa; Lidia Strigari; Mahila Ferrari; Francesca Botta; Francesco Guerriero; Concetta De Cicco; Guido Bonomo; Franco Orsi; Lisa Bodei; Amalia Di Dia; Chiara Maria Grana; Roberto Orecchia
Journal:  Front Oncol       Date:  2014-08-19       Impact factor: 6.244

Review 10.  Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.

Authors:  Etienne Garin; Yan Rolland; Sophie Laffont; Julien Edeline
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236
View more
  3 in total

1.  Radioembolization of Hepatocellular Carcinoma with 90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose-Response Analysis with Two Radiological Methods.

Authors:  Chiara Romanò; Stefania Mazzaglia; Marco Maccauro; Carlo Spreafico; Alejandro Gabutti; Gabriele Maffi; Carlo Morosi; Tommaso Cascella; Marta Mira; Maria Chiara De Nile; Gianluca Aliberti; Giovanni Argiroffi; Valentina Fuoco; Sherrie Bhoori; Consuelo Zanette; Alfonso Marchianò; Ettore Seregni; Vincenzo Mazzaferro; Carlo Chiesa
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

2.  EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Authors:  M Weber; M Lam; C Chiesa; M Konijnenberg; M Cremonesi; P Flamen; S Gnesin; L Bodei; T Kracmerova; M Luster; E Garin; K Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-11       Impact factor: 9.236

Review 3.  Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects.

Authors:  Philippe d'Abadie; Michel Hesse; Amandine Louppe; Renaud Lhommel; Stephan Walrand; Francois Jamar
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.